Syneos Health, Inc. (NASDAQ:SYNH)
About the company
Syneos Health, Inc. provides outsourced clinical development and commercialization services to biopharmaceutical companies. It operates through the following business segments: Clinical Solutions and Commercial Solutions. The Clinical Solutions segment offers clinical development services spanning Phase I to Phase IV, including global studies, as well as unbundled service offerings such as clinical monitoring, investigator recruitment, patient recruitment, data management, and study startup to assist customers with their drug development process. The Commercial Solutions segment provides commercialization services, including outsourced field selling solutions, medication adherence, communications, and consulting services. The company was founded in 1998 and is headquartered in Morrisville, NC.
Gross Margin (in %)
Operating Margin (in %)
Net Margin (in %)
Dividend Yield (in %)
|Name||Ticker||Market capitalization (in USD Million)||Revenues (in USD Million)||Price/Book||Price/Earning||Net margin (in %)|
|IQVIA Holdings, Inc.||IQV||28020.96||11158.00||4.88||129.83||1.93|
|Laboratory Corp. of America Holdings||LH||16368.94||11587.00||2.31||51.87||2.77|
|Quest Diagnostics, Inc.||DGX||15781.44||7726.00||2.74||18.48||10.33|
|Syneos Health, Inc.||SYNH||6098.18||4720.00||2.01||30.93||4.13|
|National Research Corp.||NRC||1517.10||130.00||39.43||41.68||27.51|
|Apollo Medical Holdings, Inc.||AMEH||591.12||625.00||2.96||32.84||2.89|
|Bioanalytical Systems, Inc.||BASI||57.64||55.00||5.76||-24.95||-3.94|
|Protalix Biotherapeutics, Inc.||PLX||55.95||66.00||-3.93||-5.92||-14.18|
|Interpace Biosciences, Inc.||IDXG||24.56||24.00||1.91||-0.85||-112.78|
|Pressure BioSciences, Inc.||PBIO||4.50||2.00||-0.52||-0.28||-876.69|
Latest insider transactions
|Date||Role||Name||Transaction||Quantity||Quantity Owned After|
Public Employees Retirement Association of Colorado Increases Stock Position in Syneos Health Inc (NASDAQ:SYNH)
Public Employees Retirement Association of Colorado lifted its stake in Syneos Health Inc (NASDAQ:SYNH) by 47.8% in the 1st ...
At the end of February we announced the arrival of the first US recession since 2009 and we predicted that the market will ...
Research analysts at Jefferies Financial Group lowered their Q3 2020 EPS estimates for shares of Syneos Health in a research ...
Meeder Asset Management Inc. raised its stake in Syneos Health Inc (NASDAQ:SYNH) by 245.4% during the first quarter, ...
When autocomplete results are available use up and down arrows to review and enter to select. Touch device users, explore by touch or with swipe gestures.
In Vivo CRO Market Trends Estimates High Demand By 2027 - Charles River, Covance, Iris Pharma, MELIOR DISCOVERY and Syneos Health
In Vivo CRO Market Trends Estimates High Demand By 2027 Charles River Covance Iris Pharma MELIOR DISCOVERY and Syneos Health ...
Investors in Syneos Health Inc (Symbol: SYNH) saw new options become available this week, for the August 21st expiration. At Stock Options Channel, our YieldBoost formula has looked up and down ...